The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Islet inflammation in type 2 diabetes and physiology
Open accessAbstract
The finding of islet inflammation in type 2 diabetes (T2D) and its involvement in β cell dysfunction has further highlighted the significance of inflammation in metabolic diseases. The number of intra-islet macrophages is increased in T2D, and these cells are the main source of proinflammatory cytokines within islets. Multiple human studies of T2D have shown that targeting islet inflammation has the potential to be an effective therapeutic strategy. In this Review we provide an overview of the cellular and molecular mechanisms by which islet inflammation develops and causes β cell dysfunction. We also emphasize the regulation and roles of macrophage polarity shift within islets in the context of T2D pathology and β cell health, which may have broad translational implications for therapeutics aimed at improving islet function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Maedler, K., Schumann, D., Sauter, N. S., Ellingsgaard, H., Bosco, D., Baertschiger, R. M., Iwakura, Y., Oberholzer, J., Wollheim, C. B., Gauthier, B. R., et al. (2006) · Diabetes · doi:10.2337/db05-1430 · Cited by 179
RetractedGrundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Protective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
Bauernfeind, F. G., Horvath, G., Stutz, A., Alnemri, E. S., MacDonald, K., Speert, D., Fernandes-Alnemri, T., Wu, J., Monks, B. G., Fitzgerald, K. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901363 · Cited by 2,959
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898
Macrophages, inflammation, and insulin resistance
Olefsky, J. M., & Glass, C. K. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135846 · Cited by 2,733
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Zhou, R., Tardivel, A., Thorens, B., Choi, I., & Tschopp, J. (2010) · Nature Immunology · doi:10.1038/ni.1831 · Cited by 2,708
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655
A Lineage of Myeloid Cells Independent of Myb and Hematopoietic Stem Cells
Schulz, C., Perdiguero, E. G., Chorro, L., Szabo-Rogers, H., Cagnard, N., Kierdorf, K., Prinz, M., Wu, B., Jacobsen, S. E. W., Pollard, J. W., et al. (2012) · Science · doi:10.1126/science.1219179 · Cited by 2,578
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T. (2008) · Nature Immunology · doi:10.1038/ni.1636 · Cited by 2,441
Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors
Gomez Perdiguero, E., Klapproth, K., Schulz, C., Busch, K., Azzoni, E., Crozet, L., Garner, H., Trouillet, C., de Bruijn, M. F., Geissmann, F., et al. (2015) · Nature · doi:10.1038/nature13989 · Cited by 2,339
Inflammatory links between obesity and metabolic disease
Lumeng, C. N., & Saltiel, A. R. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57132 · Cited by 2,319
Nishimura, S., Manabe, I., Nagasaki, M., Eto, K., Yamashita, H., Ohsugi, M., Otsu, M., Hara, K., Ueki, K., Sugiura, S., et al. (2009) · Nature Medicine · doi:10.1038/nm.1964 · Cited by 2,230
Self-citationTissue-Resident Macrophage Enhancer Landscapes Are Shaped by the Local Microenvironment
Lavin, Y., Winter, D., Blecher-Gonen, R., David, E., Keren-Shaul, H., Merad, M., Jung, S., & Amit, I. (2014) · Cell · doi:10.1016/j.cell.2014.11.018 · Cited by 2,167
Davies, L. C., Jenkins, S. J., Allen, J. E., & Taylor, P. R. (2013) · Nature Immunology · doi:10.1038/ni.2705 · Cited by 2,096
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
How dying cells alert the immune system to danger
Kono, H., & Rock, K. L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2215 · Cited by 1,737
Fatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling
Wen, H., Gris, D., Lei, Y., Jha, S., Zhang, L., Huang, M. T.-H., Brickey, W. J., & Ting, J. P.-Y. (2011) · Nature Immunology · doi:10.1038/ni.2022 · Cited by 1,698
Vogl, T., Tenbrock, K., Ludwig, S., Leukert, N., Ehrhardt, C., van Zoelen, M. A. D., Nacken, W., Foell, D., van der Poll, T., Sorg, C., et al. (2007) · Nature Medicine · doi:10.1038/nm1638 · Cited by 1,418
Normalization of obesity-associated insulin resistance through immunotherapy
Winer, S., Chan, Y., Paltser, G., Truong, D., Tsui, H., Bahrami, J., Dorfman, R., Wang, Y., Zielenski, J., Mastronardi, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2001 · Cited by 1,370
Masters, S. L., Dunne, A., Subramanian, S. L., Hull, R. L., Tannahill, G. M., Sharp, F. A., Becker, C., Franchi, L., Yoshihara, E., Chen, Z., et al. (2010) · Nature Immunology · doi:10.1038/ni.1935 · Cited by 1,330
Gosselin, D., Link, V. M., Romanoski, C. E., Fonseca, G. J., Eichenfield, D. Z., Spann, N. J., Stender, J. D., Chun, H. B., Garner, H., Geissmann, F., et al. (2014) · Cell · doi:10.1016/j.cell.2014.11.023 · Cited by 1,307
Colony-stimulating factors in inflammation and autoimmunity
Hamilton, J. A. (2008) · Nature reviews. Immunology · doi:10.1038/nri2356 · Cited by 1,305
Cooper, G. J., Willis, A. C., Clark, A., Turner, R. C., Sim, R. B., & Reid, K. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8628 · Cited by 1,299
Macrophage Polarization Comes of Age
Mantovani, Sica, & Locati, M. (2005) · Immunity · doi:10.1016/j.immuni.2005.10.001 · Cited by 1,259
Bain, C. C., Bravo-Blas, A., Scott, C. L., Gomez Perdiguero, E., Geissmann, F., Henri, S., Malissen, B., Osborne, L. C., Artis, D., & Mowat, A. M. (2014) · Nature Immunology · doi:10.1038/ni.2967 · Cited by 1,178
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92172 · Cited by 1,114
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
Epstein, F. H., Atkinson, M. A., & Maclaren, N. K. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411243312107 · Cited by 1,078
Westermark, P., Wernstedt, C., Wilander, E., Hayden, D. W., O'Brien, T. D., & Johnson, K. H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.11.3881 · Cited by 976
Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus
Lorenzo, A., Razzaboni, B., Weir, G. C., & Yankner, B. A. (1994) · Nature · doi:10.1038/368756a0 · Cited by 820
Increased Number of Islet-Associated Macrophages in Type 2 Diabetes
Ehses, J. A., Perren, A., Eppler, E., Ribaux, P., Pospisilik, J. A., Maor-Cahn, R., Gueripel, X., Ellingsgaard, H., Schneider, M. K. J., Biollaz, G., et al. (2007) · Diabetes · doi:10.2337/db06-1650 · Cited by 783
HMGB1: Endogenous Danger Signaling
Klune, J. R., Dhupar, R., Cardinal, J., Billiar, T. R., & Tsung, A. (2008) · Molecular Medicine · doi:10.2119/2008-00034.klune · Cited by 762
Targeting inflammation in the treatment of type 2 diabetes: time to start
Donath, M. Y. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4275 · Cited by 690
Endocannabinoid signaling at the periphery: 50 years after THC
Maccarrone, M., Bab, I., Bíró, T., Cabral, G. A., Dey, S. K., Di Marzo, V., Konje, J. C., Kunos, G., Mechoulam, R., Pacher, P., et al. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.02.008 · Cited by 646
Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis
Haataja, L., Gurlo, T., Huang, C. J., & Butler, P. C. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0037 · Cited by 612
Ferrannini, E., Gastaldelli, A., Miyazaki, Y., Matsuda, M., Mari, A., & DeFronzo, R. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1133 · Cited by 540
Saturated Fatty Acid and TLR Signaling Link β Cell Dysfunction and Islet Inflammation
Eguchi, K., Manabe, I., Oishi-Tanaka, Y., Ohsugi, M., Kono, N., Ogata, F., Yagi, N., Ohto, U., Kimoto, M., Miyake, K., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.01.023 · Cited by 519
Self-citationBrissova, M., Shostak, A., Shiota, M., Wiebe, P. O., Poffenberger, G., Kantz, J., Chen, Z., Carr, C., Jerome, W. G., Chen, J., et al. (2006) · Diabetes · doi:10.2337/db06-0690 · Cited by 442
Lech, M., & Anders, H.-J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.12.001 · Cited by 418
Miller, Y. I., Viriyakosol, S., Binder, C. J., Feramisco, J. R., Kirkland, T. N., & Witztum, J. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209634200 · Cited by 399
Hume, D. A., Robinson, A. P., MacPherson, G. G., & Gordon, S. (1983) · The Journal of experimental medicine · doi:10.1084/jem.158.5.1522 · Cited by 392
Jourdan, T., Godlewski, G., Cinar, R., Bertola, A., Szanda, G., Liu, J., Tam, J., Han, T., Mukhopadhyay, B., Skarulis, M. C., et al. (2013) · Nature Medicine · doi:10.1038/nm.3265 · Cited by 388
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller‐Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15318 · Cited by 363
Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance
Tam, J., Cinar, R., Liu, J., Godlewski, G., Wesley, D., Jourdan, T., Szanda, G., Mukhopadhyay, B., Chedester, L., Liow, J.-S., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.07.002 · Cited by 356
IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat
Ehses, J. A., Lacraz, G., Giroix, M.-H., Schmidlin, F., Coulaud, J., Kassis, N., Irminger, J.-C., Kergoat, M., Portha, B., Homo-Delarche, F., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810087106 · Cited by 347
Böni-Schnetzler, M., Boller, S., Debray, S., Bouzakri, K., Meier, D. T., Prazak, R., Kerr-Conte, J., Pattou, F., Ehses, J. A., Schuit, F. C., et al. (2009) · Endocrinology · doi:10.1210/en.2009-0543 · Cited by 339
The pancreas anatomy conditions the origin and properties of resident macrophages
Calderon, B., Carrero, J. A., Ferris, S. T., Sojka, D. K., Moore, L., Epelman, S., Murphy, K. M., Yokoyama, W. M., Randolph, G. J., & Unanue, E. R. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20150496 · Cited by 321
M2 macrophages promote beta-cell proliferation by up-regulation of SMAD7
Xiao, X., Gaffar, I., Guo, P., Wiersch, J., Fischbach, S., Peirish, L., Song, Z., El-Gohary, Y., Prasadan, K., Shiota, C., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321347111 · Cited by 312
Hepatocyte Toll-like receptor 4 regulates obesity-induced inflammation and insulin resistance
Jia, L., Vianna, C. R., Fukuda, M., Berglund, E. D., Liu, C., Tao, C., Sun, K., Liu, T., Harper, M. J., Lee, C. E., et al. (2014) · Nature Communications · doi:10.1038/ncomms4878 · Cited by 294
Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes
Cavelti-Weder, C., Babians-Brunner, A., Keller, C., Stahel, M. A., Kurz-Levin, M., Zayed, H., Solinger, A. M., Mandrup-Poulsen, T., Dinarello, C. A., & Donath, M. Y. (2012) · Diabetes Care · doi:10.2337/dc11-2219 · Cited by 294
Mechanism of IAPP amyloid fibril formation involves an intermediate with a transient β-sheet
Buchanan, L. E., Dunkelberger, E. B., Tran, H. Q., Cheng, P.-N., Chiu, C.-C., Cao, P., Raleigh, D. P., de Pablo, J. J., Nowick, J. S., & Zanni, M. T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314481110 · Cited by 274
Senescence regulates macrophage activation and angiogenic fate at sites of tissue injury in mice
Kelly, J., Khan, A. A., Yin, J., Ferguson, T. A., & Apte, R. S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32430 · Cited by 249
Rodriguez-Calvo, T., Ekwall, O., Amirian, N., Zapardiel-Gonzalo, J., & von Herrath, M. G. (2014) · Diabetes · doi:10.2337/db14-0549 · Cited by 241
Islet-associated macrophages in type 2 diabetes
Richardson, S. J., Willcox, A., Bone, A. J., Foulis, A. K., & Morgan, N. G. (2009) · Diabetologia · doi:10.1007/s00125-009-1410-z · Cited by 239
Igoillo-Esteve, M., Marselli, L., Cunha, D. A., Ladrière, L., Ortis, F., Grieco, F. A., Dotta, F., Weir, G. C., Marchetti, P., Eizirik, D. L., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1707-y · Cited by 227
Westwell-Roper, C. Y., Ehses, J. A., & Verchere, C. B. (2014) · Diabetes · doi:10.2337/db13-0863 · Cited by 224
Ehses, J. A., Meier, D. T., Wueest, S., Rytka, J., Boller, S., Wielinga, P. Y., Schraenen, A., Lemaire, K., Debray, S., Van Lommel, L., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1747-3 · Cited by 222
Islet Inflammation and Fibrosis in a Spontaneous Model of Type 2 Diabetes, the GK Rat
Homo-Delarche, F., Calderari, S., Irminger, J.-C., Gangnerau, M.-N., Coulaud, J., Rickenbach, K., Dolz, M., Halban, P., Portha, B., & Serradas, P. (2006) · Diabetes · doi:10.2337/db05-1526 · Cited by 213
Amylin secretion from the rat pancreas and its selective loss after streptozotocin treatment.
Ogawa, A., Harris, V, McCorkle, S. K., Unger, R. H., & Luskey, K. L. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114528 · Cited by 205
Brissova, M., Aamodt, K., Brahmachary, P., Prasad, N., Hong, J.-Y., Dai, C., Mellati, M., Shostak, A., Poffenberger, G., Aramandla, R., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.02.001 · Cited by 205
Sauter, N. S., Schulthess, F. T., Galasso, R., Castellani, L. W., & Maedler, K. (2008) · Endocrinology · doi:10.1210/en.2007-1059 · Cited by 198
He, H., Xu, J., Warren, C. M., Duan, D., Li, X., Wu, L., & Iruela-Arispe, M. L. (2012) · Blood · doi:10.1182/blood-2012-04-422758 · Cited by 194
Westwell-Roper, C., Dai, D. L., Soukhatcheva, G., Potter, K. J., van Rooijen, N., Ehses, J. A., & Verchere, C. B. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002854 · Cited by 190
Sloan-Lancaster, J., Abu-Raddad, E., Polzer, J., Miller, J. W., Scherer, J. C., De Gaetano, A., Berg, J. K., & Landschulz, W. H. (2013) · Diabetes Care · doi:10.2337/dc12-1835 · Cited by 184
Insulin cell mass is altered in Csf1op/Csf1op macrophage-deficient mice
Banaei-Bouchareb, L., Gouon-Evans, V., Samara-Boustani, D., Castellotti, M. C., Czernichow, P., Pollard, J. W., & Polak, M. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1103591 · Cited by 174
van Asseldonk, E. J. P., Stienstra, R., Koenen, T. B., Joosten, L. A. B., Netea, M. G., & Tack, C. J. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2992 · Cited by 173
Quantitative Studies of Amyloid in the Islets of Langerhans
Westermark, P. (1972) · Upsala Journal of Medical Sciences · doi:10.1517/03009734000000014 · Cited by 170
The IL-1 Pathway in Type 2 Diabetes and Cardiovascular Complications
Herder, C., Dalmas, E., Böni-Schnetzler, M., & Donath, M. Y. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.08.001 · Cited by 168
Cucak, H., Grunnet, L. G., & Rosendahl, A. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0213075 · Cited by 164
Butcher, M. J., Hallinger, D., Garcia, E., Machida, Y., Chakrabarti, S., Nadler, J., Galkina, E. V., & Imai, Y. (2014) · Diabetologia · doi:10.1007/s00125-013-3116-5 · Cited by 160
Abderrahmani, A., Niederhäuser, G., Favre, D., Abdelli, S., Ferdaoussi, M., Yang, J. Y., Regazzi, R., Widmann, C., & Waeber, G. (2007) · Diabetologia · doi:10.1007/s00125-007-0642-z · Cited by 158
Immune mechanisms in type 1 diabetes
Wållberg, M., & Cooke, A. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.08.005 · Cited by 155
Rissanen, A., Howard, C. P., Botha, J., Thuren, T. Y., & for the Global Investigators (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01637.x · Cited by 153
Macrophages and islet inflammation in type 2 diabetes
Eguchi, K., & Manabe, I. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12168 · Cited by 152
Self-citationFull-length Rat Amylin Forms Fibrils Following Substitution of Single Residues from Human Amylin
Green, J., Goldsbury, C. S., Mini, T., Sunderji, S., Frey, P., Kistler, J., Cooper, G. J. S., & Aebi, U. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)01377-3 · Cited by 132
The relation of islet amyloid to the clinical type of diabetes
Maloy, A. L., Longnecker, D. S., & Greenberg, E. R. (1981) · Human Pathology · doi:10.1016/s0046-8177(81)80197-9 · Cited by 124
The RISC Investigators, Mari, A., Tura, A., Natali, A., Laville, M., Laakso, M., Gabriel, R., Beck-Nielsen, H., & Ferrannini, E. (2010) · Diabetologia · doi:10.1007/s00125-009-1647-6 · Cited by 120
Zhao, H., Lai, F. M., Tong, P. C. Y., Zhong, D., Yang, D., Tomlinson, B., & Chan, J. C. N. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2759 · Cited by 117
The Molecular Basis of Distinct Aggregation Pathways of Islet Amyloid Polypeptide
Wei, L., Jiang, P., Xu, W., Li, H., Zhang, H., Yan, L., Chan‐Park, M. B. E., Liu, X., Tang, K., Mu, Y., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.166678 · Cited by 115
Hull, R. L., Andrikopoulos, S., Verchere, C. B., Vidal, J., Wang, F., Cnop, M., Prigeon, R. L., & Kahn, S. E. (2003) · Diabetes · doi:10.2337/diabetes.52.2.372 · Cited by 109
Macrophages in the murine pancreas and their involvement in fetal endocrine development in vitro
Geutskens, S. B., Otonkoski, T., Pulkkinen, M.-A., Drexhage, H. A., & Leenen, P. J. M. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.1004624 · Cited by 109
Ikeda, H. (1994) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(94)90268-2 · Cited by 109
Criscimanna, A., Coudriet, G. M., Gittes, G. K., Piganelli, J. D., & Esni, F. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.008 · Cited by 108
Xiao, X., Wiersch, J., El-Gohary, Y., Guo, P., Prasadan, K., Paredes, J., Welsh, C., Shiota, C., & Gittes, G. K. (2013) · Diabetes · doi:10.2337/db12-1428 · Cited by 102
Kamata, K., Mizukami, H., Inaba, W., Tsuboi, K., Tateishi, Y., Yoshida, T., & Yagihashi, S. (2014) · Amyloid · doi:10.3109/13506129.2014.937857 · Cited by 100
Fox, N. W., Schrementi, J. P., Nishi, M., Ohagi, S., Chan, S. J., Heisserman, J. A., Westermark, G. T., Leckström, A., Westermark, P., & Steiner, D. F. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81444-5 · Cited by 90
Agudo, J., Ayuso, E., Jiménez, V., Casellas, A., Mallol, C., Salavert, A., Tafuro, S., Obach, M., Ruzo, A., Moya, M., et al. (2012) · Diabetes · doi:10.2337/db12-0134 · Cited by 89
Interleukin-1 signaling contributes to acute islet compensation
Hajmrle, C., Smith, N. P., Spigelman, A. F., Dai, X.-Q., Senior, L., Bautista, A., Ferdaoussi, M., & MacDonald, P. E. (2016) · JCI Insight · doi:10.1172/jci.insight.86055 · Cited by 88
Meier, D. T., Morcos, M., Samarasekera, T., Zraika, S., Hull, R. L., & Kahn, S. E. (2014) · Diabetologia · doi:10.1007/s00125-014-3304-y · Cited by 82
Hume, D. A., & Gordon, S. (1983) · The Journal of Experimental Medicine · Cited by 81
Westwell-Roper, C. Y., Chehroudi, C., Denroche, H. C., Courtade, J. A., Ehses, J. A., & Verchere, C. B. (2014) · Diabetologia · doi:10.1007/s00125-014-3447-x · Cited by 78
Cao, X., Han, Z., Zhao, H., & Liu, Q. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.06.003 · Cited by 72
Mast cells infiltrate pancreatic islets in human type 1 diabetes
Martino, L., Masini, M., Bugliani, M., Marselli, L., Suleiman, M., Boggi, U., Nogueira, T. C., Filipponi, F., Occhipinti, M., Campani, D., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3734-1 · Cited by 69
Eguchi, K., & Manabe, I. (2014) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.22533 · Cited by 68
Self-citationMinireview: Emerging Concepts in Islet Macrophage Biology in Type 2 Diabetes
Morris, D. L. (2015) · Molecular Endocrinology · doi:10.1210/me.2014-1393 · Cited by 66
Islet‐expressed TLR2 and TLR4 sense injury and mediate early graft failure after transplantation
Krüger, B., Yin, N., Zhang, N., Yadav, A., Coward, W. R., Lal, G., Zang, W., Heeger, P. S., Bromberg, J. S., Murphy, B. T., et al. (2010) · European Journal of Immunology · doi:10.1002/eji.201040601 · Cited by 60
Critical Roles for Macrophages in Islet Angiogenesis and Maintenance During Pancreatic Degeneration
Tessem, J. S., Jensen, J. N., Pelli, H., Dai, X.-M., Zong, X.-H., Stanley, E. R., Jensen, J. N., & DeGregori, J. V. (2008) · Diabetes · doi:10.2337/db07-1577 · Cited by 60
Westwell-Roper, C. Y., Denroche, H. C., Ehses, J. A., & Verchere, C. B. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.712455 · Cited by 56
A transient microenvironment loaded mainly with macrophages in the early developing human pancreas
Banaei-Bouchareb, L., Peuchmaur, M. M., Czernichow, P., & Polak, M. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06225 · Cited by 55
Gassen, N. V., Overmeire, E. V., Leuckx, G., Heremans, Y., Groef, S. D., Cai, Y., Elkrim, Y., Gysemans, C. A., Stijlemans, B., de Casteele, M. V., et al. (2015) · European Journal of Immunology · doi:10.1002/eji.201445013 · Cited by 53
Impact of Islet Autoimmunity on the Progressive β-Cell Functional Decline in Type 2 Diabetes
Brooks‐Worrell, B., Boyko, E. J., & Palmer, J. P. (2014) · Diabetes Care · doi:10.2337/dc14-0961 · Cited by 52
Islet inflammation in type 2 diabetes
Marchetti, P. (2016) · Diabetologia · doi:10.1007/s00125-016-3875-x · Cited by 51
Human Islet Amyloid Polypeptide Accumulates at Similar Sites in Islets of Transgenic Mice and Humans
de Koning, E. J. P., Höppener, J. W. M., Verbeek, J. S., Oosterwijk, C., van Hulst, K. L., Baker, C. A., Lips, C. J. M., Morris, J. F., & Clark, A. (1994) · Diabetes · doi:10.2337/diab.43.5.640 · Cited by 42
Macrophages and pancreatic islet amyloidosis
de Koning, E. J. P., van den Brand, J., Mott, V. L., CHARGÉ, S. B. P., Hansen, B. C., Bodkin, N. L., Morris, J. F., & Clark, A. (1998) · Amyloid · doi:10.3109/13506129809007297 · Cited by 42
Badman, M. K., Pryce, R. A., CHARGÉ, S. B. P., Morris, J. F., & Clark, A. (1998) · Cell and Tissue Research · doi:10.1007/s004410050998 · Cited by 40
Islet Amyloid and Fibrosis in the Cardiometabolic Syndrome and Type 2 Diabetes Mellitus
Hayden, M. R. (2007) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4564.2007.06159.x · Cited by 37
Rohrbach, K. W., Thomas, M. A., Glick, S., Fung, E., Wang, V., Watson, L., Gregory, P., Antel, J., & Pelleymounter, M. A. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01563.x · Cited by 33
Islet Allograft Rejection Is Independent of Toll-Like Receptor Signaling in Mice
Hutton, M. J. H., Westwell-Roper, C. Y., Soukhatcheva, G., Plesner, A., Dutz, J. P., & Verchere, C. B. (2009) · Transplantation · doi:10.1097/tp.0b013e3181bd3fe2 · Cited by 25
Cited by
Inflammatory mechanisms linking obesity and metabolic disease
Saltiel, A. R., & Olefsky, J. M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92035 · Cited by 2,212
An Integrated View of Immunometabolism
Lee, Y. S., Wollam, J., & Olefsky, J. M. (2018) · Cell · doi:10.1016/j.cell.2017.12.025 · Cited by 436
Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection
Montefusco, L., Ben Nasr, M., D’Addio, F., Loretelli, C., Rossi, A., Pastore, I., Daniele, G., Abdelsalam, A., Maestroni, A., Dell’Acqua, M., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00407-6 · Cited by 423
The role of macrophages in obesity-associated islet inflammation and β-cell abnormalities
Ying, W., Fu, W., Lee, Y. S., & Olefsky, J. M. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0286-3 · Cited by 391
Bonnet, F., & Scheen, A. J. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.09.005 · Cited by 308
Metadata
- Authors
- Eguchi, K., & Nagai, R.
- Venue
- Journal of Clinical Investigation
- Published
- 2017-01-03
- Volume
- 127
- Issue
- 1
- Pages
- 14-23
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- OpenAlex
- W2566820606
- Cited by
- 361
- References
- 113
- FWCI
- 27.54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.